Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-23-062210
Filing Date
2023-11-09
Accepted
2023-11-09 17:01:57
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 s-3_shelf_registration_n.htm S-3 593224
2 EX-4.9 life-ex4_9.htm EX-4.9 470775
3 EX-4.12 life-ex4_12.htm EX-4.12 192006
4 EX-4.13 life-ex4_13.htm EX-4.13 235300
5 EX-4.14 life-ex4_14.htm EX-4.14 159814
6 EX-5.1 life-ex5_1.htm EX-5.1 40096
7 EX-23.1 life-ex23_1.htm EX-23.1 3681
8 EX-FILING FEES life-exfiling_fees.htm EX-FILING FEES 77278
9 GRAPHIC img106332022_0.jpg GRAPHIC 29364
10 GRAPHIC img262981699_0.jpg GRAPHIC 17192
11 GRAPHIC img262981699_1.jpg GRAPHIC 17192
  Complete submission text file 0000950170-23-062210.txt   1861411
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275455 | Film No.: 231393576
SIC: 2836 Biological Products, (No Diagnostic Substances)